Zhejiang Haisen Pharmaceutical Co., Ltd.

SZSE:001367 Stock Report

Market Cap: CN¥2.8b

Zhejiang Haisen Pharmaceutical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Lin Ai

Chief executive officer

CN¥633.1k

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership3.9%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Zhejiang Haisen Pharmaceutical's (SZSE:001367) Shareholders May Want To Dig Deeper Than Statutory Profit

May 01
Zhejiang Haisen Pharmaceutical's (SZSE:001367) Shareholders May Want To Dig Deeper Than Statutory Profit

CEO

Lin Ai (63 yo)

no data

Tenure

CN¥633,100

Compensation

Mr. Lin Ai is Director & General Manager of Zhejiang Haisen Pharmaceutical Co., Ltd. from October 10, 2017.